EE200200670A - S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks - Google Patents

S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks

Info

Publication number
EE200200670A
EE200200670A EEP200200670A EEP200200670A EE200200670A EE 200200670 A EE200200670 A EE 200200670A EE P200200670 A EEP200200670 A EE P200200670A EE P200200670 A EEP200200670 A EE P200200670A EE 200200670 A EE200200670 A EE 200200670A
Authority
EE
Estonia
Prior art keywords
methyldihydroziprasidone
psychiatric
treatment
ocular disorders
ocular
Prior art date
Application number
EEP200200670A
Other languages
English (en)
Estonian (et)
Inventor
Aggarwal Prakash Chandra
Annette Smolarek Teresa
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26903852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200670(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE200200670A publication Critical patent/EE200200670A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200200670A 2000-06-02 2001-05-28 S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks EE200200670A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20913600P 2000-06-02 2000-06-02
US21217200P 2000-06-16 2000-06-16
PCT/IB2001/000933 WO2001091756A2 (en) 2000-06-02 2001-05-28 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders

Publications (1)

Publication Number Publication Date
EE200200670A true EE200200670A (et) 2004-08-16

Family

ID=26903852

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200670A EE200200670A (et) 2000-06-02 2001-05-28 S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks

Country Status (44)

Country Link
US (1) US20060287336A1 (xx)
EP (3) EP1468686B1 (xx)
JP (2) JP2003534381A (xx)
KR (1) KR20030007824A (xx)
CN (1) CN1431901A (xx)
AP (2) AP1747A (xx)
AR (1) AR028937A1 (xx)
AT (3) ATE343387T1 (xx)
AU (1) AU2001258690A1 (xx)
BG (1) BG107267A (xx)
BR (1) BR0111271A (xx)
CA (1) CA2410618A1 (xx)
CY (1) CY1105992T1 (xx)
CZ (1) CZ20023860A3 (xx)
DE (3) DE60124791T2 (xx)
DK (1) DK1468686T3 (xx)
DO (1) DOP2001000181A (xx)
EA (1) EA007068B1 (xx)
EC (1) ECSP024369A (xx)
EE (1) EE200200670A (xx)
ES (1) ES2277170T3 (xx)
GE (1) GEP20053512B (xx)
HN (1) HN2001000119A (xx)
HR (1) HRP20020953A2 (xx)
HU (1) HUP0301747A2 (xx)
IL (2) IL152782A0 (xx)
IS (1) IS6619A (xx)
MA (1) MA26908A1 (xx)
MX (1) MXPA02011862A (xx)
NO (1) NO325077B1 (xx)
NZ (1) NZ551012A (xx)
OA (1) OA12267A (xx)
PA (1) PA8518301A1 (xx)
PE (1) PE20011329A1 (xx)
PL (1) PL365576A1 (xx)
PT (2) PT1698338E (xx)
SI (1) SI1468686T1 (xx)
SK (1) SK16622002A3 (xx)
SV (1) SV2002000473A (xx)
UA (1) UA79425C2 (xx)
UY (1) UY26742A1 (xx)
WO (1) WO2001091756A2 (xx)
YU (1) YU90702A (xx)
ZA (1) ZA200209665B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419493B2 (en) 2002-12-13 2008-09-02 Regents Of The University Of Minnesota Scleral depressor
WO2005040160A2 (en) 2003-10-24 2005-05-06 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
ES2250001B1 (es) * 2004-09-29 2007-06-01 Medichem, S.A. Proceso para la purificacion de ziprasidona.
JP2012174228A (ja) * 2011-02-24 2012-09-10 Kyocera Corp プログラム保護装置および通信装置
EP3610890A1 (en) 2012-11-14 2020-02-19 The Johns Hopkins University Methods and compositions for treating schizophrenia
US9981041B2 (en) * 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW491847B (en) * 1996-05-07 2002-06-21 Pfizer Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
NZ332219A (en) * 1996-05-07 2005-02-25 Pfizer Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1H)-indol-2-one (ziprasidone), its preparation and its use as dopamine D2 antagonist
PT985414E (pt) * 1998-05-26 2004-01-30 Pfizer Prod Inc Metodo de tratamento de glaucoma e retinopatia isquemica
AU4062900A (en) * 1999-04-06 2000-10-23 Sepracor, Inc. Methods and compositions for the treatment of neuroleptic and related disorders using ziprasidone metabolites

Also Published As

Publication number Publication date
SV2002000473A (es) 2002-10-24
SI1468686T1 (sl) 2007-04-30
EP1468686A3 (en) 2004-12-01
ES2277170T3 (es) 2007-07-01
CZ20023860A3 (cs) 2004-01-14
YU90702A (sh) 2005-11-28
DE60133596D1 (de) 2008-05-21
CY1105992T1 (el) 2011-04-06
PE20011329A1 (es) 2002-01-15
EP1286672B1 (en) 2006-10-25
ATE391507T1 (de) 2008-04-15
GEP20053512B (en) 2005-05-10
PT1468686E (pt) 2007-01-31
PT1698338E (pt) 2008-06-03
IS6619A (is) 2002-11-14
BR0111271A (pt) 2003-06-10
UA79425C2 (en) 2007-06-25
AU2001258690A1 (en) 2001-12-11
NO20025760D0 (no) 2002-11-29
HRP20020953A2 (en) 2005-02-28
EA200201168A1 (ru) 2003-06-26
NO325077B1 (no) 2008-01-28
HUP0301747A2 (hu) 2003-09-29
WO2001091756A3 (en) 2002-09-26
JP2008056700A (ja) 2008-03-13
IL152782A (en) 2007-10-31
EA007068B1 (ru) 2006-06-30
AR028937A1 (es) 2003-05-28
NO20025760L (no) 2003-01-15
US20060287336A1 (en) 2006-12-21
DE60124093D1 (de) 2006-12-07
DK1468686T3 (da) 2007-03-12
AP1831A (en) 2008-02-26
AP2005003272A0 (en) 2005-03-31
CN1431901A (zh) 2003-07-23
EP1698338A3 (en) 2006-09-20
ZA200209665B (en) 2003-11-28
EP1698338B1 (en) 2008-04-09
BG107267A (bg) 2003-06-30
MA26908A1 (fr) 2004-12-20
DE60124791D1 (de) 2007-01-04
EP1698338A2 (en) 2006-09-06
KR20030007824A (ko) 2003-01-23
EP1286672A2 (en) 2003-03-05
AP1747A (en) 2007-05-31
HN2001000119A (es) 2001-09-11
SK16622002A3 (sk) 2004-07-07
EP1468686B1 (en) 2006-11-22
WO2001091756A2 (en) 2001-12-06
MXPA02011862A (es) 2003-04-10
NZ551012A (en) 2008-04-30
IL152782A0 (en) 2003-06-24
UY26742A1 (es) 2001-12-28
ECSP024369A (es) 2003-02-06
EP1468686A2 (en) 2004-10-20
PA8518301A1 (es) 2002-09-17
PL365576A1 (en) 2005-01-10
OA12267A (en) 2004-01-20
ATE343387T1 (de) 2006-11-15
JP2003534381A (ja) 2003-11-18
DOP2001000181A (es) 2002-04-15
DE60124791T2 (de) 2007-09-13
ATE345818T1 (de) 2006-12-15
CA2410618A1 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO993051L (no) Intranasale formuleringer for behandling av seksuelle forstyrrelser
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
GB0007193D0 (en) Treatment of movrmrnt disorders
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
NO20032636D0 (no) 3-indolinderivater som er nyttige i behandlingen av psykiatriske og nevrologiske forstyrrelser
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
NO20033803D0 (no) Karbamat for behandling av bevegelseslidelser
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
NO20032156D0 (no) Behandling av angstforstyrrelser
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
AR026062A1 (es) Tratamiento de desordenes oculares
NO20010390D0 (no) Behandling av angstsykdommer
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
ID30458A (id) Osanetan dalam pengobatan gangguan jiwa